ARCOS / Harvard Drug Group / McKesson Drug Corporation / Cardinal Health / CVS Corporation / /
Country
United States / /
Currency
USD / /
Facility
University of Michigan / /
IndustryTerm
illegal Internet pharmacy operations / bulk manufacturers / rogue Internet pharmacy schemes / pharmaceutical controlled substances / controlled substance pharmaceutical drug / local law enforcement / hydrocodone products / pharmaceutical / rogue internet pharmacies / retail level registrant / controlled substance pharmaceuticals / pharmaceuticals / individual manufacturing quota / requisite law enforcement authorities / chemical handlers / prescription products / search warrants / local law enforcement officers / manufacturing quota / Internet pharmacies / dangerous and powerful pharmaceuticals / controlled substance manufacturers / manufacturing / foreign-based Internet pharmacies / pharmaceutical drugs / desired individual manufacturing quota / oxycodone products / chemicals / exempted prescription product / /
NaturalFeature
East Coast / /
Organization
University of Michigan / Ann Arbor / Internal Revenue Service / Harvard / Priority Target Organization / Centers for Disease Control and Prevention / United States Senate / Congress / Task Force / Terrorism Committee / office of Diversion Control / United States Department of Justice Subcommittee on Crime / Substance Abuse and Mental Health Services Administration / Drug Enforcement Administration / /
Person
Kyl / Whitehouse / /
Position
Acting Administrator / President / Officer / Chairman / ADMINISTRATOR / Attorney General / Intelligence Research Specialist / Special Agent / /
Microsoft Word - DEA _Leonhart_ testimony for May[removed]SJC subcommittee hearing _23MAY11_ FINAL